Evotec (ETR:EVT) Trading Down 1.3% – Here’s What Happened

Evotec SE (ETR:EVT) traded down 1.3% during mid-day trading on Thursday . The company traded as low as €6.30 ($6.77) and last traded at €6.32 ($6.79). 509,397 shares changed hands during mid-day trading, a decline of 63% from the average session volume of 1,360,000 shares. The stock had previously closed at €6.40 ($6.88).

Evotec Stock Down 1.3 %

The stock has a 50 day simple moving average of €7.76 and a 200 day simple moving average of €7.64. The company has a market capitalization of $1.17 billion, a price-to-earnings ratio of -6.83, a P/E/G ratio of 0.98 and a beta of 1.05.

Evotec Company Profile

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.